The present study first demonstrated that nicotine in CSE decreased the metabolic activation of CYP2A13 to other toxic components of CSE, which should provide a novel basis that the cytochrome P450-mediated in situ metabolism might be helpful to identify the critical components of cigarette smoking, including ETS, in human respiratory diseases. This evidence concerns the gene CYP2A13 and respiratory system disorder.